241 related articles for article (PubMed ID: 27995057)
21. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
Gil B; Merav L; Pnina L; Chagai G
Clin Rheumatol; 2016 Aug; 35(8):2125-2130. PubMed ID: 25846833
[TBL] [Abstract][Full Text] [Related]
22. Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib.
Yamazoe M; Takeda K; Nagano Y; Nagano K; Kato K; Inoue T; Horiuchi K; Kamada K
Intern Med; 2024 Feb; ():. PubMed ID: 38346740
[TBL] [Abstract][Full Text] [Related]
23. Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study.
Hara S; Ishimoto H; Sakamoto N; Mukae H; Kakugawa T; Ishimatsu Y; Mine M; Kohno S
Respiration; 2011; 81(2):107-17. PubMed ID: 21124011
[TBL] [Abstract][Full Text] [Related]
24. The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.
Osawa T; Morimoto K; Sasaki Y; Matsuda S; Yamana K; Yano R; Uchiyama T; Goto H
Intern Med; 2018 Feb; 57(3):387-391. PubMed ID: 29093381
[TBL] [Abstract][Full Text] [Related]
25. Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia.
Furusawa H; Sugiura M; Mitaka C; Inase N
Respirology; 2017 Oct; 22(7):1357-1362. PubMed ID: 28440556
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia.
Yamagata A; Arita M; Tanaka A; Tokioka F; Yoshida T; Nishimura K; Ishida T
J Clin Apher; 2020 Sep; 35(5):435-443. PubMed ID: 32810902
[TBL] [Abstract][Full Text] [Related]
27. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
Motegi SI; Sekiguchi A; Toki S; Kishi C; Endo Y; Yasuda M; Ikeuchi H; Sakairi T; Hara K; Yamaguchi K; Maeno T; Hiromura K; Ishikawa O
Eur J Dermatol; 2019 Oct; 29(5):511-517. PubMed ID: 31617496
[TBL] [Abstract][Full Text] [Related]
29. A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis.
Sasaki O; Dohi M; Harada H; Imamura M; Tsuchida Y; Yamaguchi K; Komai T; Yamamoto K
Case Rep Med; 2013; 2013():750275. PubMed ID: 23983712
[TBL] [Abstract][Full Text] [Related]
30. Effects of direct hemoperfusion with polymyxin B-immobilized fiber on rapidly progressive interstitial lung diseases.
Takada T; Asakawa K; Sakagami T; Moriyama H; Kazama J; Suzuki E; Narita I
Intern Med; 2014; 53(17):1921-6. PubMed ID: 25175123
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study.
Terada-Hirashima J; Izumi S; Katagiri D; Uemura Y; Mikami A; Sugiura W; Abe S; Azuma A; Sugiyama H
JMIR Res Protoc; 2022 Nov; 11(11):e37426. PubMed ID: 36126219
[TBL] [Abstract][Full Text] [Related]
32. An Autopsy Case of Anti-melanoma Differentiation-associated Gene-5 Antibody-positive Clinical Amyopathic Dermatomyositis Complicated by Rapidly Progressive Interstitial Lung Disease.
Yoshida N; Kaieda S; Tomozoe K; Tajiri M; Wakasugi D; Okamoto M; Tominaga M; Ida H; Hoshino T
Intern Med; 2016; 55(12):1653-9. PubMed ID: 27301523
[TBL] [Abstract][Full Text] [Related]
33. Clinically amyopathic dermatomyositis manifested after the allogeneic haematopoietic stem cell transplantation: Case presentation and literature review.
Miyagi R; Nakachi S; Tamaki Y; Doi M; Nakajima T; Kitamura S; Tomori S; Hanashiro T; Tamaki K; Morichika K; Nishi Y; Morishima S; Fukushima T; Masuzaki H
Mod Rheumatol Case Rep; 2023 Jan; 7(1):102-107. PubMed ID: 35950604
[TBL] [Abstract][Full Text] [Related]
34. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
35. Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion.
Kusaba Y; Izumi S; Takasaki J; Suzuki M; Katagiri D; Katsuno T; Matsumoto S; Sakamoto K; Hashimoto M; Ohmagari N; Katano H; Suzuki T; Hojo M; Sugiyama H
Intern Med; 2020 Oct; 59(19):2405-2408. PubMed ID: 32863364
[TBL] [Abstract][Full Text] [Related]
36. Polymyxin B-immobilized fiber column hemoperfusion treatment for drug-induced severe respiratory failure: report of three cases.
Yokoyama T; Tsushima K; Yamamoto H; Ito M; Agatsuma T; Kozumi T; Kubo K
Intern Med; 2010; 49(1):59-64. PubMed ID: 20046003
[TBL] [Abstract][Full Text] [Related]
37. Clinically amyopathic dermatomyositis presenting with isolated facial edema complicated by acute respiratory failure: a case report.
Lim DH; So MW; Kim YM; Ryu JH; Lee JH; Park CS; Kim SH; Lee S
BMC Musculoskelet Disord; 2021 Jan; 22(1):117. PubMed ID: 33509162
[TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody.
Cao H; Pan M; Kang Y; Xia Q; Li X; Zhao X; Shi R; Lou J; Zhou M; Kuwana M; Ding X; Zheng J
Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1602-10. PubMed ID: 22623119
[TBL] [Abstract][Full Text] [Related]
39. Case Report: Treatment of Anti-MDA5-Positive Amyopathic Dermatomyositis Accompanied by a Rapidly Progressive Interstitial Lung Diseases With Methylprednisolone Pulse Therapy Combined With Cyclosporine A and Hydroxychloroquine.
Zhang QC; Liu MY; Chen ZX; Chen YT; Lin CS; Xu Q
Front Med (Lausanne); 2020; 7():610554. PubMed ID: 33330573
[No Abstract] [Full Text] [Related]
40. Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations.
Aoyama J; Hayashi H; Yajima C; Takoi H; Tanaka T; Kashiwada T; Kokuho N; Terasaki Y; Nishikawa A; Gono T; Kuwana M; Saito Y; Abe S; Seike M; Gemma A
Respir Med Case Rep; 2019; 26():193-196. PubMed ID: 30723666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
